SLOW K 600 Milligram Tablet Prolonged Release Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

slow k 600 milligram tablet prolonged release

novartis pharmaceuticals uk ltd - potassium chloride - tablet prolonged release - 600 milligram

Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Euroopa Liit - inglise - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain a/viet nam/1194/2004 (h5n1) - influenza, human - vaccines - active immunisation against h5n1 subtype of influenza a virus.; this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain.; prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

AMLODIPINE/VALSARTAN NOVARTIS 5/80 amlodipine 5 mg/valsartan 80 mg film-coated tablet blister pack Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

amlodipine/valsartan novartis 5/80 amlodipine 5 mg/valsartan 80 mg film-coated tablet blister pack

novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); valsartan, quantity: 80 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; crospovidone; colloidal anhydrous silica; titanium dioxide; hypromellose; purified talc; macrogol 4000; iron oxide yellow - amlodipine/valsartan novartis is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Zometa 4mg5ml solution for infusion vials Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

zometa 4mg5ml solution for infusion vials

novartis pharmaceuticals uk ltd - zoledronic acid monohydrate - solution for infusion - 800microgram/1ml